Merck recently reported a 17% decline in sales of its HPV vaccine Gardasil in China, citing increasing price pressure from domestic manufacturers and the impact of China’s ongoing anti-corruption drive in the healthcare industry.
MNCs Face Setbacks In China?s Vaccine Market Amid | 03/07/2025 | By Darshana | 362
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy